Antidepressant Medication Unwanted Effects Such as Body Weight, BP Changes Differ Depending on Medication

• A large recent study discovered that the adverse reactions of antidepressant medications differ considerably by drug.
• Certain medications led to reduced body weight, while others resulted in increased body weight.
• Cardiac rhythm and blood pressure furthermore diverged notably across treatments.
• Individuals suffering from ongoing, intense, or concerning adverse reactions must discuss with a medical provider.

Recent studies has found that antidepressant medication side effects may be more varied than previously thought.

The extensive study, issued on October 21st, examined the influence of antidepressant drugs on over 58,000 subjects within the beginning two months of beginning therapy.

The researchers studied 151 investigations of 30 pharmaceuticals typically used to treat clinical depression. Although not every patient experiences side effects, several of the most prevalent noted in the research were fluctuations in body weight, arterial pressure, and metabolic indicators.

The study revealed significant differences across antidepressant drugs. As an illustration, an two-month regimen of one medication was linked to an average decrease in mass of around 2.4 kilograms (approximately 5.3 lbs), whereas maprotiline individuals added almost 2 kg in the identical timeframe.

Additionally, significant changes in cardiovascular activity: one antidepressant was likely to decrease heart rate, while another medication increased it, producing a difference of about 21 heartbeats per minute among the two medications. BP fluctuated as well, with an 11 mmHg variation observed across nortriptyline and doxepin.

Medical specialists commented that the research's results are not recent or surprising to mental health professionals.

"We've long known that various antidepressant medications vary in their effects on weight, blood pressure, and additional metabolic parameters," a professional explained.

"Nonetheless, what is remarkable about this research is the comprehensive, comparative measurement of these differences among a broad spectrum of physiological parameters utilizing information from more than 58,000 participants," this expert commented.

This study offers comprehensive support of the magnitude of unwanted effects, several of which are more common than others. Typical antidepressant medication adverse reactions may comprise:

• gastrointestinal symptoms (queasiness, loose stools, blockage)
• intimacy issues (lowered desire, inability to orgasm)
• weight changes (addition or decrease, depending on the medication)
• sleep problems (sleeplessness or sedation)
• mouth dryness, moisture, head pain

At the same time, less common but clinically significant unwanted effects may encompass:

• elevations in blood pressure or heart rate (particularly with SNRIs and some tricyclics)
• hyponatremia (especially in older adults, with SSRIs and SNRIs)
• liver enzyme elevations
• Corrected QT interval lengthening (risk of irregular heartbeat, notably with citalopram and some tricyclics)
• emotional blunting or apathy

"One thing to note regarding this matter is that there are various different categories of antidepressant medications, which contribute to the different adverse medication effects," another specialist explained.

"Furthermore, antidepressant drugs can impact each person differently, and adverse reactions can vary according to the particular medication, dosage, and individual elements like metabolism or co-occurring conditions."

Although several unwanted effects, such as variations in sleep, appetite, or stamina, are reasonably frequent and frequently improve with time, others may be less common or continuing.

Antidepressant medication unwanted effects may vary in seriousness, which could require a modification in your drug.

"An modification in antidepressant medication may be necessary if the patient encounters ongoing or unbearable side effects that fail to enhance with duration or supportive measures," one professional commented.

"Additionally, if there is an development of recently developed medical issues that may be aggravated by the existing medication, for instance hypertension, arrhythmia, or significant weight gain."

Patients may furthermore contemplate consulting with your physician about any absence of significant improvement in low mood or anxiety-related indicators subsequent to an sufficient trial period. An appropriate testing period is usually 4–8 weeks duration at a therapeutic amount.

Individual inclination is additionally significant. Some individuals may prefer to evade certain adverse reactions, such as intimacy issues or {weight gain|increased body weight|mass addition